Literature DB >> 21401384

Gomisin N has anti-allergic effect and inhibits inflammatory cytokine expression in mouse bone marrow-derived mast cells.

Hee-Sung Chae1, Ok-Hwa Kang, You-Chang Oh, Jang-Gi Choi, Joon-Ho Keum, Sung-Bae Kim, Yong-Sik Kim, Su-Hyun Mun, Dong-Won Shin, Sin-Hee Han, Dong-Yeul Kwon.   

Abstract

Gomisin N is a bioactive compound and a prominent anti-allergic agent found in the fruits of tree Schizandra chinensis. However, its effects on the bone marrow-derived mast cell (BMMC)-mediated allergy and inflammation mechanism remain unknown. In this study, the biological effects of gomisin were evaluated while focusing on its effects on the allergic mediator in PMA + A23187-stimulated BMMCs. The anti-allergic effect of gomisin has shown that inhibited PMA + A23187-induced interleukin-6 (IL-6) production. An investigation was also conducted to determine its effects on the production of several allergic mediators including prostaglandin D(2) (PGD(2)), leukotriene C(4) (LTC(4)), β-hexosaminidase (β-Hex), and cyclooxygenase-2 (COX-2) protein. The results revealed that gomisin inhibited the PMA + A23187-induced production of IL-6, PGD(2), LTC(4), β-Hex, and COX-2 protein. Taken together, these findings indicate that gomisin N has the potential for use in the treatment of allergy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401384     DOI: 10.3109/08923973.2011.562215

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  5 in total

1.  Gomisin N Decreases Inflammatory Cytokine Production in Human Periodontal Ligament Cells.

Authors:  Yoshitaka Hosokawa; Ikuko Hosokawa; Satoru Shindo; Kazumi Ozaki; Takashi Matsuo
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

2.  The anti-inflammatory effect of Cheongseoikki-tang ethanol extract on allergic reactions mediated by bone marrow-derived mast cells.

Authors:  Joon-Ho Keum; Ok-Hwa Kang; Sung-Bae Kim; Su-Hyun Mun; Yun-Soo Seo; Ma-Ryong Kim; Jung-Rae Rho; Young-Seob Lee; Chung-Berm Park; Young-Guk Kim; Yong-Il Kim; Sin-Hee Han; Dong-Yeul Kwon
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

3.  Gomisin M2 Inhibits Mast Cell-Mediated Allergic Inflammation via Attenuation of FcεRI-Mediated Lyn and Fyn Activation and Intracellular Calcium Levels.

Authors:  Hima Dhakal; Soyoung Lee; Eun-Nam Kim; Jin Kyeong Choi; Min-Jong Kim; Jinjoo Kang; Young-Ae Choi; Moon-Chang Baek; Byungheon Lee; Hyun-Shik Lee; Tae-Yong Shin; Gil-Saeng Jeong; Sang-Hyun Kim
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

4.  Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.

Authors:  Namkyung Kim; Soyoung Lee; Jinjoo Kang; Taeg Kyu Kwon; Dongwoo Khang; Sang-Hyun Kim
Journal:  Mol Med Rep       Date:  2021-10-19       Impact factor: 3.423

5.  Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression.

Authors:  Eun-Jung Kim; Haesu Lee; Mi Hye Kim; Woong Mo Yang
Journal:  BMC Complement Altern Med       Date:  2018-10-01       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.